Disco Pharmaceuticals

Developer of target-directed therapeutic modalities for the treatment of cancer

placeCologne, North Rhine Westphalia, Germany calendar_todayFounded 2022 language discopharma.de

Registered entities

Social engagement

Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Sofinnova Partners, Ackermans & van Haaren, NRW.Bank.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

11 Mar 2026 · BTA/MTA (m/f/d) · Cologne

19 Dec 2025 · Financial Accountant – Accounting & Administration · Cologne (DE) or Schlieren (CH)

Based on job postings tracked across public sources.

Recent activity

20 Feb 2026
Event
World ADC Summit London
4 Feb 2026
Event
Proteomics Based Drug Discovery Summit
12 Jan 2026
Leadership hire
Head of Computational Biology
Coming soon